Kosh Agarwal
0000-0002-4754-828X
404 papers found
Refreshing results…
Final Results of a Phase 1b 28-Day Study of ABI-H0731, a Novel Core Inhibitor, in Non-Cirrhotic Viremic Subjects with Chronic Hepatitis B
Nucleoside Analogue Therapy in Acute Hepatitis B Infection: A Retrospective Review of 8 Years of Experience from King's College Hospital
Assessing the Feasibility of a One Step HCV RNA Screening Test Utilising Pooled Plasma Samples: A Method to Deliver Significant Upscaling of HCV Screening?
Five- and ten-year survival in a large cohort of patients with HIV-associated non-cirrhotic portal hypertension (NCPH)
Are hepatitis delta virus (HDV) genotypes important to determine the disease progression and therapy responses?
Breaking Free from Hepatitis C - Hepatitis Treatment in South London Prisons
Tenofovir alafenamide in the treatment of chronic hepatitis B virus infection: rationale and clinical trial evidence
Three Year Efficacy and Safety of Tenofovir Alafenamide (TAF) Compared to Tenofovir Disoproxil Fumarate (TDF) in Hbeag-Negative and Hbeag-Positive Patients with Chronic Hepatitis B
Selonsertib in Combination with Prednisolone for the Treatment of Severe Alcoholic Hepatitis: A Phase 2 Randomized Controlled Trial
Sofosbuvir/Velpatasvir Is Effective and Safe in Patients with Concomitant Proton Pump Inhibitor Use in Clinical Studies
Alpha-Fetoprotein As a Predictor of Recurrence Following Liver Transplantation
Education and Targeted HCV Screening in Pregnancy Is Effective in an Ethnically Diverse, Urban Population
Modified Hbcrag Quantitation Assay Using Dynamic Dilution Enables Accurate Measurement of Hbcrag in Patients with High HBV DNA Levels
Effectiveness of Sofosbuvir/Velpatasvir for 12 Weeks in HCV Genotype 3 Patients with Compensated Cirrhosis in Clinical Practice Cohorts from Around the World
The Non-Steroidal Farnesoid X Receptor (FXR) Agonist GS-9674 Improves Liver Biochemistry and Decreases Serum Bile Acids in Patients with Primary Sclerosing Cholangitis (PSC): A Phase 2, Randomized, Placebo-Controlled Trial
Durability of Sustained Virologic Response and Liver Safety in Patients Treated with Glecaprevir/Pibrentasvir: A Long-Term Follow-up Study
TLR7 Agonist RO7020531 Triggers Immune Activation after Multiple Doses in Chronic Hepatitis B Patients
Hepatitis B Core-Related Antigen and Quantitative Surface Antigen Augment Risk Stratification of Patients with Acute Hepatitis B
A New Marker to Identify 'True' Functional Cure-Is HBsAg Loss Truly HBsAg Loss?
Response to DAA therapy in the NHS England Early Access Programme for rare HCV subtypes from low and middle income countries
Missing publications? Search for publications with a matching author name.